BIOLINERX LTD. Chart calendar BioLineRX Ltd.
77a267516af47b784d8ddd6ffd4.mjNq02rkPzp3wehAqKsd6e7ymkmBr4KQRs8JwriY8YY.3EEMgjLSR2Jas78F2PteobyI1ji56c7jD7xWgf_VsuD2Azq6PaELCjWTuQ~bff0751a42068a990c33c1eea45521dd
Upcoming events on BioLineRX Ltd.
Past events on BioLineRX Ltd.
| 16/04/2024 | American Society for Apheresis Meeting - Poster: Number P-28 |
| 26/03/2024 12:30 | Q4 2023 Earnings Call |
| 26/03/2024 11:00 | Q4 2023 Earnings Release |
| 28/02/2024 | Immuno Oncology Summit |
| 23/02/2024 00:45 | American Society for Transplantation and Cellular Therapy and CIBMTR Meeting - Poster: Number 537 |
| 23/02/2024 00:45 | American Society for Transplantation and Cellular Therapy and CIBMTR Meeting - Poster: Number 535 |
| 09/12/2023 | American Society of Hematology Meeting |
| 20/11/2023 15:00 | Q3 2023 Earnings Call |
| 20/11/2023 12:00 | Q3 2023 Earnings Release |
| 28/09/2023 19:30 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
| 27/09/2023 22:30 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
| 12/09/2023 13:00 | APHEXDA FDA Approval Call |
| 30/08/2023 15:00 | Q2 2023 Earnings Call |
| 30/08/2023 12:00 | Q2 2023 Earnings Release |
| 24/05/2023 15:00 | Q1 2023 Earnings Call |
| 24/05/2023 12:00 | Q1 2023 Earnings Release |
| 22/03/2023 14:00 | Q4 2022 Earnings Call |
| 22/03/2023 11:00 | Q4 2022 Earnings Release |
| 26/05/2021 15:00 | Q1 2021 Earnings Call |
| 26/05/2021 12:00 | Q1 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 4,80 0,17 2809.09% | 14,4 |
|
EBITDA Million USD | Released Forecast Spread | -27,2 -25,6 -6.14% | -22,0 -21,2 -3.74% | -24,1 -25,3 4.85% | -28,5 -30,4 6.24% | -49,0 -42,4 -15.54% | -59,8 |
|
EBIT Million USD | Released Forecast Spread | -28,1 -25,5 -10.3% | -22,9 -22,1 -3.9% | -24,8 -24,4 -1.47% | -29,2 -28,5 -2.31% | -49,7 -42,1 -18.08% | -39,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,4 -22,2 -14.72% | -30,0 -23,3 -28.65% | -27,1 -28,9 6.43% | -25,0 -27,1 7.87% | -60,6 -58,8 -3.05% | -47,8 |
|
Net income Million USD | Released Forecast Spread | -25,4 -22,2 -14.72% | -30,0 -23,0 -30.3% | -27,1 -28,9 6.43% | -25,0 -27,1 7.87% | -60,6 -58,8 -3.05% | -47,3 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -0,03 -0,03 0% | -0,06 -0,06 0% | -0,02 |
| Announcement Date | 12/03/20 | 23/02/21 | 16/03/22 | 22/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 4,80 0,17 2809.09% | 0,34 | 0,47 | 0,81 | 4,69 | 6,91 |
|
EBITDA Million USD | Released Forecast Spread | -12,0 -19,0 37.02% | -11,6 -12,1 4.13% | -6,42 -7,10 9.52% | -5,91 -6,60 10.52% | -7,46 -6,80 -9.72% | -13,4 -12,9 -3.62% | -6,93 -7,70 10.06% | -8,21 -9,70 15.35% | -8,60 -8,80 2.31% | -9,72 -9,30 -4.48% | -18,3 -18,1 -1.18% | -12,1 -10,1 -20.16% | -18,5 -11,3 -64.08% | -16,8 | -17,1 | -33,9 | -13,7 | -12,2 |
|
EBIT Million USD | Released Forecast Spread | -6,60 -6,23 -5.87% | -6,08 -6,80 10.55% | -7,60 -5,44 -39.87% | -7,08 -6,43 -10.1% | -8,40 -6,79 -23.69% | -8,86 -8,72 -1.61% | -9,92 -8,16 -21.58% | -18,8 -18,1 -3.71% | -12,4 -9,55 -29.36% | -18,6 -10,6 -74.44% | ||||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,4 -18,1 25.88% | -17,0 -15,6 -9.19% | -4,30 -6,15 29.96% | -4,93 -7,10 30.54% | -7,44 -5,76 -29.17% | -12,4 -11,2 -10.47% | -6,85 -6,97 1.73% | -5,73 -7,87 27.16% | -12,2 -8,74 -39.14% | -18,5 -8,62 -115.2% | -30,7 -22,5 -36.48% | -16,2 -11,0 -46.93% | -13,9 -12,1 -14.68% | -21,0 | -21,3 | -42,3 | -17,9 | -16,5 |
|
Net income Million USD | Released Forecast Spread | -13,4 -18,1 25.88% | -17,0 -15,6 -9.19% | -4,30 -6,15 29.96% | -4,93 -7,10 30.54% | -7,44 -5,76 -29.17% | -12,4 -11,2 -10.47% | -6,85 -6,97 1.73% | -5,73 -7,87 27.16% | -12,2 -8,74 -39.14% | -18,5 -8,62 -115.2% | -30,7 -22,5 -36.48% | -16,2 -11,0 -46.93% | -13,9 -12,1 -14.68% | -21,0 | -21,3 | -42,3 | -17,9 | -16,5 |
|
EPS USD | Released Forecast Spread | 0,00 -0,01 - | -0,02 -0,01 -100% | -0,02 -0,01 -100% | -0,01 -0,01 0% | ||||||||||||||
| Announcement Date | 06/08/20 | 18/08/21 | 16/03/22 | 11/05/22 | 16/08/22 | 16/08/22 | 15/11/22 | 22/03/23 | 24/05/23 | 30/08/23 | 30/08/23 | 20/11/23 | 26/03/24 | - | - | - | - | - |
More events
Past sector events for BioLineRX Ltd.
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
